Shadow AI in Clinics: ChatGPT, Copilot and Transcription Tools

Shadow AI is not usually malicious. It often starts with staff trying to save time: drafting a letter, summarising a meeting, improving a patient communication or testing a transcription tool. The governance issue is whether the organisation knows what tools are being used, whether patient data is involved and whether staff have a clear boundary between approved, conditional and prohibited use.

Who this is for

  • Practice managers
  • DPOs
  • Clinic owners
  • Boards and partners
  • Clinical governance leads

Common shadow AI examples

Checklist

  • ChatGPT used to draft patient letters
  • Microsoft Copilot used across documents or emails
  • AI meeting transcription used for clinical discussions
  • Personal-device AI assistants
  • Free-tier transcription tools
  • AI summarisation of referrals or complaints
  • Marketing AI tools using patient-related context
  • Supplier platforms with AI features switched on

Why it becomes an evidence problem

The risk is not that staff are interested in AI. The risk is having no documented governance position when a DPO, board, patient, insurer, MDO or inspector asks how AI use is controlled.

Evidence to create

Checklist

  • Confidential, role-level and non-disciplinary AI use survey
  • AI tool and use-case inventory
  • Approved, conditional and prohibited use matrix
  • Staff guidance on patient data
  • Vendor evidence tracker
  • DPIA screening records
  • Incident reporting route for AI-related issues
  • Board-level summary of AI exposure

What ELSA AI can help produce

The Diagnostic surfaces shadow AI use and structures the first evidence response.

Outputs include

  • AI Tool and Use Case Inventory
  • RAG Exposure Map
  • Staff-use evidence indicators
  • DPIA Readiness and Patient Data Exposure Note
  • 30-Day Priority Action Plan

Advisory governance support only. Not legal advice, DPIA sign-off, CQC approval, ICO approval, insurer coverage advice, MDO indemnity advice or clinical safety case sign-off. Final decisions remain with the organisation's accountable officers and advisers.

Need this evidence mapped for your clinic or group?

The Clinical AI Exposure Diagnostic™ gives clinic leadership a board-ready view of AI use, patient-data exposure, evidence gaps and priority actions in four working days from the start of delivery.

Related guides